Update History
Condition: Pancreatic cancer/melanoma syndrome
Gene/Gene Panel: CDKN2A
Context: Adult
2022/10/04
Released
2.0.0
Morbidity and mortality from melanoma
(GroupA)
Skin surveillance to detect melanoma and guide melanoma treatment
(GroupA)
9CN
Morbidity and mortality from pancreatic cancer
(GroupA)
Referral to specialist to guide surveillance plans for early detection of pancreatic cancer or precursors and guide pancreatic cancer treatment
(GroupA)
8CB
Assertions
Gene Condition Pairs
Suggested Assertion
Final Assertion
CDKN2A
⇔
0011713 MELANOMA-PANCREATIC CANCER SYNDROME
Moderate Actionability
Moderate Actionability
2022/09/02
Released
(Under revision)
1.2.2
Melanoma morbidity and/or mortality
(GroupA)
Skin surveillance
(GroupA)
10CB
Pancreatic cancer morbidity and/or mortality
(GroupA)
Periodic pancreatic imaging
(GroupA)
8CN
Smoking cessation and/or avoidance
(GroupA)
9CB
Internal system migration associated with MONDO name addition.
2022/02/09
Released
1.2.2
Melanoma morbidity and/or mortality
(GroupA)
Skin surveillance
(GroupA)
10CB
Pancreatic cancer morbidity and/or mortality
(GroupA)
Periodic pancreatic imaging
(GroupA)
8CN
Smoking cessation and/or avoidance
(GroupA)
9CB
Internal system migration associated with MONDO name addition.
2022/02/09
Released
(Under revision)
1.2.1
Melanoma morbidity and/or mortality
(GroupA)
Skin surveillance
(GroupA)
10CB
Pancreatic cancer morbidity and/or mortality
(GroupA)
Periodic pancreatic imaging
(GroupA)
8CN
Smoking cessation and/or avoidance
(GroupA)
9CB
MONDO ID added
2020/08/19
Released
1.2.1
Melanoma morbidity and/or mortality
(GroupA)
Skin surveillance
(GroupA)
10CB
Pancreatic cancer morbidity and/or mortality
(GroupA)
Periodic pancreatic imaging
(GroupA)
8CN
Smoking cessation and/or avoidance
(GroupA)
9CB
MONDO ID added
2020/08/19
Released
(Under revision)
1.2.0
Melanoma morbidity and/or mortality
(GroupA)
Skin surveillance
(GroupA)
10CB
Pancreatic cancer morbidity and/or mortality
(GroupA)
Periodic pancreatic imaging
(GroupA)
8CN
Smoking cessation and/or avoidance
(GroupA)
9CB
Internal system migration associated with Gene-Disease scoring groups upgrades.
2019/10/03
Released
1.2.0
Melanoma morbidity and/or mortality
(GroupA)
Skin surveillance
(GroupA)
10CB
Pancreatic cancer morbidity and/or mortality
(GroupA)
Periodic pancreatic imaging
(GroupA)
8CN
Smoking cessation and/or avoidance
(GroupA)
9CB
Internal system migration associated with Gene-Disease scoring groups upgrades.
2019/04/04
Released
1.1.0
Melanoma morbidity and/or mortality
Skin surveillance
10CB
Pancreatic cancer morbidity and/or mortality
Periodic pancreatic imaging
8CN
Smoking cessation and/or avoidance
9CB
Internal system migration related to merging adult and pediatric contexts.
2018/11/01
Released
1.0.2
Melanoma morbidity and/or mortality
Skin surveillance
10CB
Pancreatic cancer morbidity and/or mortality
Periodic pancreatic imaging
8CN
Smoking cessation and/or avoidance
9CB
Internal system migration related to score text replacement from E to N
2018/01/10
Released
1.0.1
Melanoma morbidity and/or mortality
Skin surveillance
10CB
Pancreatic cancer morbidity and/or mortality
Periodic pancreatic imaging
8CE
Smoking cessation and/or avoidance
9CB
2017/09/08
Released
1.0.0
Melanoma morbidity and/or mortality
Skin surveillance
10CB
Pancreatic cancer morbidity and/or mortality
Periodic pancreatic imaging
8CE
Smoking cessation and/or avoidance
9CB